[go: up one dir, main page]

BR9707210A - Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos - Google Patents

Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos

Info

Publication number
BR9707210A
BR9707210A BR9707210A BR9707210A BR9707210A BR 9707210 A BR9707210 A BR 9707210A BR 9707210 A BR9707210 A BR 9707210A BR 9707210 A BR9707210 A BR 9707210A BR 9707210 A BR9707210 A BR 9707210A
Authority
BR
Brazil
Prior art keywords
ihrh
antiestrogens
analogs
treatment
pharmaceutical combination
Prior art date
Application number
BR9707210A
Other languages
English (en)
Inventor
Klaus Stoeckemann
Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9707210A publication Critical patent/BR9707210A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9707210A 1996-01-29 1997-01-29 Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos BR9707210A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
PCT/EP1997/000395 WO1997027863A1 (de) 1996-01-29 1997-01-29 Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen

Publications (1)

Publication Number Publication Date
BR9707210A true BR9707210A (pt) 1999-04-06

Family

ID=7784640

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707210A BR9707210A (pt) 1996-01-29 1997-01-29 Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos

Country Status (20)

Country Link
US (3) US7309691B2 (pt)
EP (1) EP0877621A1 (pt)
JP (1) JP2000505422A (pt)
KR (1) KR19990082080A (pt)
CN (1) CN1209750A (pt)
BG (1) BG63248B1 (pt)
BR (1) BR9707210A (pt)
CZ (1) CZ239198A3 (pt)
DE (1) DE19604231A1 (pt)
EA (1) EA001178B1 (pt)
HU (1) HUP9901288A3 (pt)
IL (1) IL125557A0 (pt)
MX (1) MX9806082A (pt)
NO (1) NO983465L (pt)
PL (1) PL328066A1 (pt)
SK (1) SK98798A3 (pt)
TR (1) TR199801452T2 (pt)
TW (1) TW577735B (pt)
WO (1) WO1997027863A1 (pt)
ZA (1) ZA97741B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
HU228736B1 (en) * 1998-04-23 2013-05-28 Zentaris Ivf Gmbh Use of lhrh atnagonists in the production of pharmaceutical compostion for the treatment of fertility disorders
SK287192B6 (sk) * 1999-08-31 2010-02-08 Bayer Schering Pharma Aktiengesellschaft Mezoprogestíny (modulátory receptora pre progesterón) na liečenie a prevenciu benígnych gynekologických ochorení závislých od hormónov
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
JP2003509467A (ja) * 1999-09-23 2003-03-11 ツェンタリス アクチエンゲゼルシャフト 子宮内膜組織の子宮外の増殖、慢性骨盤痛およびファロピウス管閉塞症を治療する方法
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
WO2002002144A1 (fr) * 2000-07-05 2002-01-10 Takeda Chemical Industries, Ltd. Preparations medicinales pour le traitement des maladies dependant des hormones sexuelles
DE10050831A1 (de) 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
CA2458452C (en) * 2001-08-10 2011-04-19 Takeda Chemical Industries, Ltd. Gnrh agonist combination drugs
US7705011B2 (en) 2005-03-16 2010-04-27 Masao Igarashi Agent for treatment and prevention of endometriosos and uterine adenomyosis
EP2266568A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
KR20140089402A (ko) * 2010-06-16 2014-07-14 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US6096764A (en) 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration

Also Published As

Publication number Publication date
TW577735B (en) 2004-03-01
SK98798A3 (en) 1999-03-12
BG63248B1 (bg) 2001-07-31
CZ239198A3 (cs) 1998-11-11
US20010041672A1 (en) 2001-11-15
HUP9901288A2 (hu) 1999-08-30
US20020198155A1 (en) 2002-12-26
DE19604231A1 (de) 1997-07-31
EA001178B1 (ru) 2000-10-30
US7309691B2 (en) 2007-12-18
BG102660A (en) 1999-06-30
KR19990082080A (ko) 1999-11-15
EP0877621A1 (de) 1998-11-18
ZA97741B (en) 1997-07-30
TR199801452T2 (xx) 1998-10-21
JP2000505422A (ja) 2000-05-09
EA199800666A1 (ru) 1999-02-25
US20020032156A1 (en) 2002-03-14
WO1997027863A1 (de) 1997-08-07
NO983465L (no) 1998-09-18
NO983465D0 (no) 1998-07-28
HUP9901288A3 (en) 2000-03-28
CN1209750A (zh) 1999-03-03
MX9806082A (es) 1998-10-31
IL125557A0 (en) 1999-03-12
PL328066A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
BR9707210A (pt) Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
BR9507656A (pt) Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
FI952169A7 (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
IL131318A0 (en) Sulfonamides for treatment of endothelin-mediated disorders
BR9701673A (pt) Disposição para a aplicação de um líquido medicinal
BR9507771A (pt) Processos para preparação de ácido 1-Butil-2-(2'-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto
HUP0201791A3 (en) The use of escitalopram for treatment of neurotic disorders
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
AU2739497A (en) Use of vitamin d analogs for the treatment of arthritic disease
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
NO996194D0 (no) Anvendelse av en farmasoeytisk sammensetning til behandling av traumatisk artritt hos hester
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006.